Form 4 Filing for Alpha Tau Medical Ltd.

2026-06-04SEC Filing 4 (0001213900-26-065201)

Raphi Levy, Chief Financial Officer of Alpha Tau Medical Ltd., reported the disposition of 17,500 ordinary shares on June 3, 2026, at a price of $10.9005 per share, and 15,000 ordinary shares on June 3, 2026, at a price of $10.7571 per share. Following these transactions, Mr. Levy directly owns 147,680 ordinary shares.